Dermaprime Therapeutics Llp - Due diligence report
A 360° intelligence report on Dermaprime Therapeutics Llp: trust score, financial health, credit view, compliance, directors, growth and dis…
- Unlock all financial figures & 5-year trends
- Full trust, health & credit-risk scores
- Director details, charges & MCA documents
- One credit unlocks this full due-diligence report
- Use across any company’s report, anytime
- Credits valid for 12 months
Dermaprime Therapeutics Llp — 360° Intelligence Report
Generated from MCA filings & public recordsDermaprime Therapeutics Llp is assessed as Low Risk with a Trust Score of 84/100. Dermaprime Therapeutics Llp is an active limited liability partnership incorporated in 2022, operating in the Wood sector. Processed financial statements are not yet available for trend analysis. Based on MCA filings and public records, it currently shows a low compliance risk and an unassessed financial risk profile.
Report generated on 14 Oct 2026 from the latest processed filings. Dermaprime Therapeutics Llp snapshot & full profile →
Automated indicators derived from public MCA / GST / EPFO records - not a credit rating, not investment, legal or financial advice. Spotted an inaccuracy? Report an error.
Score Card
Higher is safer · rule-based & explainableFinancial Intelligence Dashboard
No processed financialsCredit & Compliance Intelligence
Why the scores are what they are- Financial statements needed for a credit view.
Charges position: 0 open (-) · 0 satisfied (-).
- Company status is Active as per MCA.
- Balance sheet slightly behind (Mar 2025).
Director Intelligence
Stability score: 95/100| Name | DIN / PAN | Designation | Appointed | Tenure | DIN status |
|---|---|---|---|---|---|
| TANYA ROY CHOWDHURY | 01234567 | Director | 01/04/2018 | 6 yrs | Approved |
| SUBHASHISH ROY CHOUDHARY | 01234567 | Director | 01/04/2018 | 6 yrs | Approved |
| SHIKHA ROYCHOWDHURY | 01234567 | Director | 01/04/2018 | 6 yrs | Approved |
| ENAKSHEE ROY CHOWDHARY | 01234567 | Director | 01/04/2018 | 6 yrs | Approved |
- 4 directors on the board.
- No disqualified or deactivated DINs.
- Stable board - no exits in 3 years.
Ownership & Group Intelligence
Full shareholding pattern, group structure & capital events →
Risk Intelligence Center
Growth N/A · Distress 90Stakeholder Verdicts
Vendor · Banker · Investor- Statutory record is clean.
- No distress signals on file.
- No financials on record - ask for audited statements.
- No filed financials - rely on banking statements and GST data.
- No existing security registered - first-charge position available.
- Compliance record supports lending.
- No clear growth signals in the filed years.
- Request management accounts - public filings insufficient.
- Management team looks stable.
MCA Filings & Events Timeline
Latest 7 eventsKey Observations
Auto-generated from the data above| Company | CIN | Location |
|---|---|---|
| Sustainova Life Care Private Limited | U21009GJ2024PTC151684 | Ahmedabad, Gujarat |
| Aegle Life Care Private Limited | U51101GJ2014PTC079138 | Ahmedabad, Gujarat |
| AETHON ESOLUTIONS LLP | AAY-3315 | Ahmedabad, Gujarat |
| Praful Reed And Heald Frame Private Limited | U29268GJ2007PTC050614 | Ahmedabad, Gujarat |
| Star Machine Engineers Private Limited | U29100GJ2007PTC051257 | Ahmedabad, Gujarat |
| Dinar Logistics Private Limited | U63030GJ2021PTC124974 | Ahmedabad, Gujarat |
| Kronos Metalcraft Private Limited | U28990GJ2019PTC108482 | Ahmedabad, Gujarat |
| Hetal Realty Private Limited | U45201GJ2006PTC048406 | Ahmedabad, Gujarat |
| Nirdesh Technology Private Limited | U58191GJ2023PTC144017 | Ahmedabad, Gujarat |
| Dipak Trends Private Limited | U18205GJ2020PTC114319 | Ahmedabad, Gujarat |
Who Uses This Report
CA · CS · Banker · Investor · VendorVerify Dermaprime Therapeutics Llp before audits and certifications: compliance score 88/100, filing history, auditor history and charge records in one place - instead of pulling each MCA form separately.
Track statutory health of Dermaprime Therapeutics Llp: ACTIVE compliance status, annual-return recency, director DIN status, board churn and the events timeline - the inputs for secretarial audits and due-diligence certificates.
Current banker verdict: Favourable lending indicators. Credit risk score pending financials, existing charge position and lender relationships - a first-pass credit memo before formal appraisal.
Investor view: Mixed indicators. Growth score n/a, margin trends, ownership structure and peer set for Dermaprime Therapeutics Llp - screening before a deeper diligence.
Vendor verdict: Favourable indicators. Trust score 84/100, distress signals and MSME payment-delay disclosures - know whether Dermaprime Therapeutics Llp pays its suppliers before you extend credit terms.
Litigation footprint (no cases on record), regulatory flags, charge documents trail and director networks for Dermaprime Therapeutics Llp - groundwork for KYC, onboarding and disputes.
Frequently Asked Questions
Is Dermaprime Therapeutics Llp an active company?
Dermaprime Therapeutics Llp has MCA status “Active” with a compliance score of 88/100 (Low Risk).
Is Dermaprime Therapeutics Llp financially healthy?
Processed financial statements are not yet available for Dermaprime Therapeutics Llp, so its financial health is unassessed.
Should I do business with Dermaprime Therapeutics Llp?
Its overall Trust Score is 84/100 (Low Risk). Vendor verdict: Favourable indicators. Review the risk flags in the Risk Intelligence Center before deciding.
Who controls Dermaprime Therapeutics Llp?
See the directors and ownership sections above for board and shareholding detail. 4 active director(s) are on record.
Does Dermaprime Therapeutics Llp have loans or charges against its assets?
No charges are registered against this company - an unencumbered balance sheet.
Is Dermaprime Therapeutics Llp up to date with its ROC filings?
Balance sheet slightly behind (Mar 2025). Overall compliance score: 88/100 (Low Risk).
Is it risky to lend to Dermaprime Therapeutics Llp?
Filed financial statements are needed for a credit view - ask the company for audited statements and bank statements.